Susceptibilities of cefiderocol, meropenem-xeruborbactam, cefepime-taniborbactam, aztreonam-avibactam, and sulbactam-durlobactam against imipenem-non-susceptible Gram-negative bacilli in Taiwan

Cefiderocol showed >90% susceptibility across all species. The susceptibilities of meropenem-xeruborbactam (XEM), cefepime-taniborbactam (FTB), and aztreonam-avibactam (AZA) were 72-96% for 29 INS-EC; 95-97% for 138 INS-KP; and 0-95% for 135 INS-AB; and 32-70% for 85 INS-PA. Sulbactam-durlobactam (SUD) was active against 93% of INS-AB. Cefiderocol, XEM, and AZA retained >80% activity against class B carbapenemase-producing INS-EC/KP. Cefiderocol, XEM, and SUD showed >90% activity against bla<sub>OXA-23/24-like</sub> INS-AB. Reduced FTB activity in INS-EC was associated with both YRIK/YRIN insertion in penicillin-binding protein 3 (PBP3) and carbapenemase genes or bla<sub>IMP</sub> alone, whereas reduced AZA activity was linked to PBP3 alteration or bla<sub>CMY-42.</sub> CONCLUSIONS: Cefiderocol was highly effective, whereas novel β-lactam/β-lactamase inhibitors activity varied by species and carbapenemase types. PBP3 alterations reduced FTB and AZA activity in INS-EC.

Authors

Institutions

Publication Details

Journal
International Journal of Infectious Diseases
Published
2025-12-04
DOI
https://doi.org/10.1016/j.ijid.2025.108279
Citations
2
Primary Topic
Antibiotic Resistance in Bacteria
Type
article
Field-Weighted Citation Impact
1.18

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Susceptibilities of cefiderocol, meropenem-xeruborbactam, cefepime-taniborbactam, aztreonam-avibactam, and sulbactam-durlobactam against imipenem-non-susceptible Gram-negative bacilli in Taiwan

Peijing Chen, I‐Wen Huang, Yih‐Ru Shiau, Jui‐Fen Lai et al.
2 citations
International Journal of Infectious Diseases
Antibiotic Resistance in Bacteria
1.18
article

Susceptibilities of cefiderocol, meropenem-xeruborbactam, cefepime-taniborbactam, aztreonam-avibactam, and sulbactam-durlobactam against imipenem-non-susceptible Gram-negative bacilli in Taiwan

Peijing Chen, I‐Wen Huang, Yih‐Ru Shiau, Jui‐Fen Lai, Shu‐Chen Kuo, Yu-Lin Lee, Ya‐Sung Yang, Mei-Chen Tan, Hui-Ying Wang, Yanru Wang
article en
2 citations

Abstract

Cefiderocol showed >90% susceptibility across all species. The susceptibilities of meropenem-xeruborbactam (XEM), cefepime-taniborbactam (FTB), and aztreonam-avibactam (AZA) were 72-96% for 29 INS-EC; 95-97% for 138 INS-KP; and 0-95% for 135 INS-AB; and 32-70% for 85 INS-PA. Sulbactam-durlobactam (SUD) was active against 93% of INS-AB. Cefiderocol, XEM, and AZA retained >80% activity against class B carbapenemase-producing INS-EC/KP. Cefiderocol, XEM, and SUD showed >90% activity against bla<sub>OXA-23/24-like</sub> INS-AB. Reduced FTB activity in INS-EC was associated with both YRIK/YRIN insertion in penicillin-binding protein 3 (PBP3) and carbapenemase genes or bla<sub>IMP</sub> alone, whereas reduced AZA activity was linked to PBP3 alteration or bla<sub>CMY-42.</sub> CONCLUSIONS: Cefiderocol was highly effective, whereas novel β-lactam/β-lactamase inhibitors activity varied by species and carbapenemase types. PBP3 alterations reduced FTB and AZA activity in INS-EC.

International Journal of Infectious DiseasesVol. 163
National Health Research Institutes (TW), Chung Shan Medical University Hospital (TW), National Defense Medical Center (TW), Chung Shan Medical University (TW)
Tungs' Taichung MetroHarbor Hospital, Cathay General Hospital, Chang Gung Medical Foundation, Kaohsiung Medical University, National Health Research Institutes, National Cheng Kung University Hospital, Shionogi, Far Eastern Memorial Hospital, Changhua Christian Hospital, National Cheng Kung University, Taichung Veterans General Hospital, Sin-Lau Hospital, Tri-Service General Hospital, Kaohsiung Medical University Chung-Ho Memorial Hospital, Taipei Veterans General Hospital, Kaohsiung Veterans General Hospital, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Kaohsiung Armed Forces General Hospital, Lo-Hsu Medical Foundation, Lotung Poh-Ai Hospital, National Science and Technology Council, Centers for Disease Control and Prevention, Kaohsiung Chang Gung Memorial Hospital
Openalex Percentile: Top 18%
Antibiotic Resistance in Bacteria
1.18
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.